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Small colony variants (SCVs) 
• SCVs are bacterial subpopulation that grow slowly and form 
smaller colonies
• SCVs have been described for a wide range of bacterial species. 
They have been most extensively studied for Staphylococci
• They are considered as mutants. Majority of them are auxotrophic 
to hemin, thiamine or thymidine. In the presence of auxotrophic 
agents, they revert to normal growth 
• Can be selected using aminoglycoside antibiotics 
• Are tolerant to many antibiotics
• Are implicated in chronic and persistent infections
Proctor, R. A. et al. 2006. Nature Reviews Microbiology 4: 295-305
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Current Knowledge on SCVs 
• Mutations in genes involved in hemin, thiamine or menadione 
production results in reduced TCA cycle metabolism and 
consequently reduced electron transport (ET), yielding SCVs
• Uptake of aminoglycoside antibiotics (kanamycin, gentamicin etc.) 
depend on bacterial membrane potential which in turn depend on 
ET. Hence reduced ET results in reduced uptake of 
aminoglycosides.
•  Aminoglycosides, thus, can be used to select SCVs
Proctor, R. A. et al. 2006. Nature Reviews Microbiology 4: 295-305
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Small colony variants
Normal Staphylococcus aureus (a) and their SCVs (b) grown on Columbia blood agar plates
Proctor, R. A. et al. 2006. Nature Reviews Microbiology 4: 295-305. 
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• Switch between SCV and normal (revertant) phenotype may occur when 
bacteria is exposed to cycles of gentamicin followed by antibiotic free 
medium (1)
• SCVs have the ability to enter into and persist within epithelial and 
endothelial cells (2) 
• They have low levels of  toxin production, are more resistant to 
intracellular host defence and show decreased activation of host immune 
system (3)
• Frequency of SVCs vary and most of them are reported to be isolated 
from clinical cases exposed to long antibiotic therapy (4). 
• In one study (4), no SCVs of S.aureus were recovered from 10 patients 
who did not receive gentamicin beads indicating that SCVs can be 
isolated only in certain conditions
Current Knowledge on SCVs (cont.)
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Isolation of E.coli and Salmonella enteriticus  
SCVs 
• 50 µl of E.coli DH5α, BL21 DE-3 and Salmonella 
enteriticus grown overnight, was added to 3 ml LB 
medium containing 0, 10, 20, 30, 40, 50, 60 and 70 
µg kanamycin and incubated at 37 degrees for 48h
• Cells were plated on LB agar  
Jacob, Jaison. 2009. Available from Nature Precedings    
http://hdl.handle.net/10101/npre.2009.1411.2
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Isolation of SCVs- critical steps
• Stage of bacterial growth: stationary phase bacterial cultures have 
more SCVs and hence should be used
• Initial size of inoculum: If high, some normal bacteria may escape 
killing, which will repopulate on antibiotic-free medium giving false 
negative results
 
• To ensure complete killing of normal bacteria, 50 µl of sample was 
withdrawn when the cells incubated with kanamicin reached an 
O.D. of 0.2 to 0.3, and was added to fresh LB medium containing 
the same concentrations of kanamicin. This was followed by 
incubation for 48 hNatu
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Results 
• SCVs could be isolated from any normal colonies of E.coli DH5α, 
BL21 DE-3 and Salmonella enteriticus
• SCVs were not a single subpopulation, but rather comprise many 
subpopulations. As concentration of kanamycin increased, the size of 
colonies decreased sequentially
• No switching between SCVs and normal phenotype noticed
• Slow growing bacteria can be removed after repeatedly growing in 
early exponential phase. However, they reappeared following 
overnight incubation
• SCVs have reduced GFP expression  
Jacob, Jaison. 2009. Available from Nature Precedings    
http://hdl.handle.net/10101/npre.2009.1411.2
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Results
A
BA. Subpopulations of SCVs 
isolated using different 
kanamycin concentrations
B. GFP expression levels of 
different subpopulations 
by western blot
C. GFP expression using 
immunoflouroscence
Jacob, Jaison. 2009. Available from Nature Precedings    
http://hdl.handle.net/10101/npre.2009.1411.2
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Conclusion
• Majority of SCVs are senescent bacteria that do not 
revert to normal phenotype
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Senescent bacteria
• The uptake of aminoglycosides into bacteria depends on their 
membrane potential (MP)
• In many species, MP reduces with age due to reduced expression of 
electron transport (ET) pathway and seems to be a common signature 
of aging (5)
 
• Even though lifespan varies greatly between species, the level of age 
regulation of ET pathway is nearly the same (5)
 
• It can be assumed that this is true in bacteria also
• Young, active bacteria may have high MP resulting in a higher uptake 
of aminoglycoside leading to their rapid elimination. Aging bacteria 
may have low MP and escape killing due to reduced uptake and are 
thus selectively grown. 
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Types of SCVs and their growth characteristics
• Most SCVs are considered as mutants
• However, my findings indicate that majority of them can be 
senescent bacteria
• Senescent bacteria and mutants can be differentiated by growing 
them in medium containing known auxotrophic agents
• Apart from these two, bacteria under repair or those which have a 
transient growth inhibition may also form SCVs. They are normal 
bacteria that do not grow during repair phase and hence form 
small colonies. After penicillin treatment, many SCVs can be 
isolated that revert to large colonies on subcultureNa
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Types of SCVs and their growth characteristics
largelargeBacteria under repair
smallsmallSenescent bacteria
largesmallRespiratory deficient mutants
Rich mediaMinimal media
Colony sizes on subcultureType of bacteria forming SCVs
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Aminoglycoside resistance by SCVs
• At 60 µg/ml of kanamycin, no growth of E.coli was noticed 
• At 50 µg/ml, SCVs were isolated, that, when grown were resistant 
to even 100 µg/ml of kanamycin
• If SCVs were mutants, they could have been isolated from parent 
culture itself treated with 100 µg/ml of kanamycin
• ‘ Mutant theory’  thus cannot explain the increased antibiotic 
resistance by SCVs
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Aminoglycoside resistance by senescent bacteria
• In the parent culture, senescent bacteria can not divide more as 
they have the growth disadvantage. By the time the culture reaches 
stationary phase, it mostly consists of fast growing young 
population
 
• However, on removal of fast growing population by kanamycin, 
senescent bacteria are selected which then can further divide and 
give rise to more senescent ones which are more tolerant to 
aminoglycosides as they have still lower membrane potential
• Thus, the production of still more aged bacterial population can 
explain the increased resistance of SCVs to kanamycinN
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At stationary phase, most of the 
bacteria are normal fast dividing 
ones. Senescent bacteria is unable 
to divide further due to their growth 
disadvantage.
After kanamycin treatment, fast 
growing bacteria are selectively 
killed, leaving senescent ones, which 
further divides to give rise to more 
senescent ones, that are more 
resistant to kanamycin due to its 
reduced uptake resulting from their 
still lower membrane potential
At stationary phase
After kanamycin treatment
Aminoglycoside resistance by senescent bacteria
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Concentration dependent killing of aminoglycosides
• Aminoglycosides exhibit concentration dependent killing (unlike penicillin group 
which exhibit time dependent killing)
• Senescent bacteria can explain this phenomenon
• At low aminoglycoside concentrations, only the young, fast dividing bacteria are 
killed, leaving senescent, slow dividing, small colony forming bacteria
• With increasing concentrations, more and more of the senescent bacteria are 
killed till it reaches MBC, wherein all bacteria are killed
• Thus, killing of bacteria by aminoglycosides depends on the antibiotic  
concentration
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Long post-antibiotic effect (PAE) of 
aminoglycosides
• PAE is the period of time after removal of an antibiotic 
during which there is no growth of the bacteria (6)
• Aminoglycosides exhibit long post-antibiotic effect
• Senescent bacteria can explain this phenomenon
• At concentrations below MBC, fast growing bacteria are 
selectively killed, leaving mainly slow growing bacteria 
which takes longer time for re-growth
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Long PAE of aminoglycosides
PAE of aminoglycosides can be increased by
• Increasing the concentration of aminoglycosides (more slow growing bacteria are 
selected; hence take longer time for growth)
• Increasing the time of incubation (more ‘ perfect’  killing of fast dividing normal 
bacteria)
• Using optimal initial inoculum size (a high initial inoculum size may not kill all 
normal, fast dividing bacteria)
Penicillin exhibit low PAE (there is no selection of slow growing bacteria; hence 
bacteria that survives are normal population which grow immediately)Na
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E.Coli killing by penicillin and aminoglycosides
A. Area at the zone of inhibition after kanamycin treatment consists of only small colonies. Larger colonies are seen radiating 
out as the antibiotic concentration decreases. 
B. Persisters remaining after ampicillin treatment. The zone of inhibition is abrupt 
and has both large and small colonies.
Jacob, Jaison. 2009. Available from Nature Precedings    
http://hdl.handle.net/10101/npre.2009.1411.2
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New findings and hypothesis on SCVs
Most of them do not pose public health hazards as they are 
less virulent and do not revert. Mutants may pose threats.
Pose public health hazards
Tolerant to antibiotics; but can be killed by increasing the 
duration of treatment (except by aminoglycosides)
Tolerant to many antibiotics
Few may cause chronic infections. Higly senescent bacteria 
may not cause chronic infection
Responsible for chronic infections
Less virulentAre less virulent
Senescent bacteria do not revert; mutants revert in presence 
of auxotrophic agents
Revert in the presence of auxotrophic agents
Can be isolated from any colonies sensitive to 
aminoglycosides
Can be isolated from a few colonies only
Majority are normal senescent bacteria; occasionally 
mutants may also be present
Are mutants
SCVs consists of a number of subpopulations with different 
growth rates
SCVs are reported as single subpopulation
New findings and hypothesisCurrent Knowledge
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Future directions
Senescent bacteria- a gold mine for immunologists?
• As bacteria undergoes senescence, they exhibit less growth rate, form 
small colonies and are less virulent
• More knowledge on the regulation of virulence can be obtained by 
studying bacterial subpopulations of increasing senescence
• Senescent bacteria are potential live vaccines as they do not revert 
and are less virulent
• They are good model for aging and epigenetics researchNatu
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Senescent bacteria as potential live vaccines
‘ Senescent bacterial vaccines’  have the potential to become an effective 
and ideal group of vaccines because
• They may elicit good immune responses as they are live and are capable of 
multiplication.
• Their virulence is, predictably, very low. They are slow dividing and exhibit 
reduced virulence, electron transport chain pathway, GFP levels etc.
• Reversion frequency may be low or absent as they are attenuated naturally by 
aging.
• The use of naturally attenuated bacteria stimulates immune responses to antigen 
in their natural conformation itself and can be superior to the traditional methods 
of attenuation. 
Other predictable advantages of ‘ senescent bacterial vaccines’  include
• Easy to isolate senescent bacteria required for vaccine development 
• Vaccines can possibly be developed against most vaccine preventable diseases 
of bacterial origin as aging can be a universal phenomenon. 
• Prior knowledge on virulent proteins/genes not required.
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Conclusions
• SCVs comprises many subpopulations
• SCVs can be isolated from any bacterial colonies sensitive to aminoglycosides
• Isolation of SCVs alone may not indicate chronic infections
• Concentration dependent killing by aminoglycosides can be explained by senescent 
bacteria
• Long PAE of aminoglycosides can be explained by senescent bacteria
• Aminoglycoside resistance by SCVs can be explained by bacterial senescence, but not 
by ‘ mutant theory’
• Senescent bacteria is an important source of bacterial heterogeneity and noise in 
protein expression
                                                      Proposal
• Senescent bacteria can be potential live vaccines
• They can be excellent models for future studies in aging, epigenetics and immunology
                                  Prediction
• SCVs can still be isolated from hemB mutants (auxotrophic to hemin) and menD 
mutants (auxotrophic to menadione) grown in the presence of hemin and menadione 
respectively 
• Logic: Mutants will revert to normal bacteria in the presence of auxotrophic agents 
which on further mutiplication will give rise to senescent bacteria that will form SCVs 
which will not revert in the presence of these agents
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